Study of XNW28012 for advanced pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new drug called XNW28012 for people with advanced pancreatic cancer that has grown after at least one prior treatment. The goal is to see if the drug can help control the cancer and to check its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic cancer that has spread to other parts of the body and has gotten worse after at least one previous treatment.
- You are 18 years or older.
- You are generally able to take care of yourself (ECOG performance status 0 or 1).
- Your organs (like kidneys, liver, and bone marrow) are working well enough, as shown by recent blood tests.
- You are expected to live at least 12 weeks.
- If you could become pregnant, you must have a negative pregnancy test and agree to use effective birth control during the study and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination of experimental drugs plus standard chemotherapy for people with advanced pancreatic cancer that has spread. The goal is to see if adding these drugs can help shrink tumors or slow the cancer's growth better than chemotherapy alone.
This trial tests a new drug, XNW28012, for people with advanced pancreatic cancer that has worsened after two standard chemotherapy treatments. The drug targets a protein called tissue factor on cancer cells, which might help slow or stop the cancer's growth.
This trial tests a new drug called XNW28012 for people with advanced solid tumors that have not responded to or caused side effects from standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called XNW29016 for people with advanced cancer that has stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called LM-108 combined with chemotherapy for people with advanced pancreatic cancer that hasn't been treated before. The goal is to see if it's safe and may help shrink tumors or stop them from growing.
This trial tests an experimental drug for people with advanced pancreatic cancer that has spread or cannot be removed by surgery. It aims to see if the drug can shrink tumors and improve outcomes.
Hear when a new Metastatic Pancreatic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.